Abdus Sobur receives a 2025 Global Recognition Award for developing artificial intelligence models that support earlier ...

Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise.

A blood-based colorectal cancer (CRC) screening test, SimpleScreen™, has shown a significant leap in performance, ...

Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise.

Conventional diagnostic tools, such as ultrasound, MRI, PET, CT scans, and scintigraphy, often identify cancer only at later stages. These methods can be expensive, expose patients to radiation, and ...

TrialTranslator uncovers the survival gap for high-risk patients and offers a path to better cancer research. Study: Evaluating generalizability of oncology trial results to real-world patients using ...

The firm has developed a whole-blood mRNA test intended for use as a screening tool in women at elevated risk of breast cancer.

Galleri is a blood test that aims to detect over 50 types of cancer early. It analyzes cell-free DNA (cfDNA) and methylation patterns to identify potential cancer signals. The test is intended for ...